annual shareholders equity:
$727.63M+$339.75M(+87.59%)Summary
- As of today (July 1, 2025), CPRX annual stockholders equity is $727.63 million, with the most recent change of +$339.75 million (+87.59%) on December 31, 2024.
- During the last 3 years, CPRX annual shareholders equity has risen by +$520.80 million (+251.80%).
- CPRX annual shareholders equity is now at all-time high.
Performance
CPRX Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$794.28M+$66.65M(+9.16%)Summary
- As of today (July 1, 2025), CPRX quarterly stockholders equity is $794.28 million, with the most recent change of +$66.65 million (+9.16%) on March 31, 2025.
- Over the past year, CPRX quarterly shareholders equity has increased by +$232.87 million (+41.48%).
- CPRX quarterly shareholders equity is now at all-time high.
Performance
CPRX quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CPRX Shareholders equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +87.6% | +41.5% |
3 y3 years | +251.8% | +260.7% |
5 y5 years | +730.4% | +696.9% |
CPRX Shareholders equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +251.8% | at high | +229.4% |
5 y | 5-year | at high | +730.4% | at high | +614.3% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
CPRX Shareholders equity History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $794.28M(+9.2%) |
Dec 2024 | $727.63M(+87.6%) | $727.63M(+10.1%) |
Sep 2024 | - | $660.94M(+8.6%) |
Jun 2024 | - | $608.65M(+8.4%) |
Mar 2024 | - | $561.41M(+44.7%) |
Dec 2023 | $387.88M(+29.1%) | $387.88M(+11.3%) |
Sep 2023 | - | $348.55M(-7.1%) |
Jun 2023 | - | $375.29M(+12.5%) |
Mar 2023 | - | $333.66M(+11.1%) |
Dec 2022 | $300.42M(+45.2%) | $300.42M(+11.3%) |
Sep 2022 | - | $270.04M(+12.0%) |
Jun 2022 | - | $241.09M(+9.5%) |
Mar 2022 | - | $220.22M(+6.5%) |
Dec 2021 | $206.83M(+22.0%) | $206.83M(+4.1%) |
Sep 2021 | - | $198.66M(+5.1%) |
Jun 2021 | - | $188.94M(+5.8%) |
Mar 2021 | - | $178.65M(+5.3%) |
Dec 2020 | $169.60M(+93.5%) | $169.60M(+8.3%) |
Sep 2020 | - | $156.63M(+40.9%) |
Jun 2020 | - | $111.20M(+11.6%) |
Mar 2020 | - | $99.68M(+13.7%) |
Dec 2019 | $87.63M(+72.6%) | $87.63M(+12.4%) |
Sep 2019 | - | $77.98M(+23.2%) |
Jun 2019 | - | $63.28M(+23.7%) |
Mar 2019 | - | $51.18M(+0.8%) |
Dec 2018 | $50.78M(-37.3%) | $50.78M(-20.7%) |
Sep 2018 | - | $64.08M(-9.8%) |
Jun 2018 | - | $71.06M(-6.8%) |
Mar 2018 | - | $76.25M(-5.8%) |
Dec 2017 | $80.96M(+106.0%) | $80.96M(+155.2%) |
Sep 2017 | - | $31.73M(-6.6%) |
Jun 2017 | - | $33.97M(-3.2%) |
Mar 2017 | - | $35.10M(-10.7%) |
Dec 2016 | $39.31M(-29.1%) | $39.31M(-8.4%) |
Sep 2016 | - | $42.90M(-7.4%) |
Jun 2016 | - | $46.33M(-8.3%) |
Mar 2016 | - | $50.54M(-8.9%) |
Dec 2015 | $55.48M | $55.48M(-8.5%) |
Sep 2015 | - | $60.65M(-3.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $62.79M(-5.7%) |
Mar 2015 | - | $66.62M(+89.0%) |
Dec 2014 | $35.24M(+64.8%) | $35.24M(-3.8%) |
Sep 2014 | - | $36.62M(-11.1%) |
Jun 2014 | - | $41.19M(+133.5%) |
Mar 2014 | - | $17.64M(-17.5%) |
Dec 2013 | $21.39M(+46.3%) | $21.39M(-3.3%) |
Sep 2013 | - | $22.12M(+124.7%) |
Jun 2013 | - | $9.84M(-23.8%) |
Mar 2013 | - | $12.92M(-11.6%) |
Dec 2012 | $14.62M(+288.8%) | $14.62M(+55.6%) |
Sep 2012 | - | $9.39M(+46.5%) |
Jun 2012 | - | $6.41M(+136.0%) |
Mar 2012 | - | $2.72M(-27.8%) |
Dec 2011 | $3.76M(-31.8%) | $3.76M(-3.0%) |
Sep 2011 | - | $3.88M(-21.8%) |
Jun 2011 | - | $4.95M(-21.2%) |
Mar 2011 | - | $6.28M(+13.9%) |
Dec 2010 | $5.52M(-27.6%) | $5.52M(-8.0%) |
Sep 2010 | - | $6.00M(+10.9%) |
Jun 2010 | - | $5.41M(-18.7%) |
Mar 2010 | - | $6.66M(-12.6%) |
Dec 2009 | $7.62M(-27.9%) | $7.62M(+60.0%) |
Sep 2009 | - | $4.76M(-20.3%) |
Jun 2009 | - | $5.97M(-22.1%) |
Mar 2009 | - | $7.67M(-27.4%) |
Dec 2008 | $10.56M(-35.3%) | $10.56M(-25.0%) |
Sep 2008 | - | $14.08M(+10.5%) |
Jun 2008 | - | $12.75M(-15.0%) |
Mar 2008 | - | $15.00M(-8.1%) |
Dec 2007 | $16.32M(-17.8%) | $16.32M(-5.0%) |
Sep 2007 | - | $17.19M(-3.6%) |
Jun 2007 | - | $17.83M(-5.4%) |
Mar 2007 | - | $18.85M(-5.0%) |
Dec 2006 | $19.85M(+4344.9%) | $19.85M(+602.4%) |
Sep 2006 | - | $2.83M(-4183.1%) |
Jun 2006 | - | -$69.20K(-115.5%) |
Dec 2005 | $446.50K(+279.7%) | $446.50K(+279.7%) |
Dec 2004 | $117.60K(+161.9%) | $117.60K |
Dec 2002 | $44.90K | - |
FAQ
- What is Catalyst Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual shareholders equity year-on-year change?
- What is Catalyst Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Catalyst Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of CPRX is $727.63M
What is the all time high annual shareholders equity for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual stockholders equity is $727.63M
What is Catalyst Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, CPRX annual stockholders equity has changed by +$339.75M (+87.59%)
What is Catalyst Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of CPRX is $794.28M
What is the all time high quarterly shareholders equity for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly stockholders equity is $794.28M
What is Catalyst Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, CPRX quarterly stockholders equity has changed by +$232.87M (+41.48%)